title: Idd9/11 genetic locus regulates diabetogenic activity of CD4 T-cells in nonobese diabetic (NOD) mice.
abstract: OBJECTIVE
  Although the H2(g7) major histocompatibility complex (MHC) provides the primary pathogenic component, the development of T-cell-mediated autoimmune type 1 diabetes in NOD mice also requires contributions from other susceptibility (Idd) genes. Despite sharing the H2(g7) MHC, the closely NOD-related NOR strain remains type 1 diabetes resistant because of contributions of protective Idd5.2, Idd9/11, and Idd13 region alleles. To aid their eventual identification, we evaluated cell types in which non-MHC Idd resistance genes in NOR mice exert disease-protective effects.
  
  
  METHODS
  Adoptive transfer and bone marrow chimerism approaches tested the diabetogenic activity of CD4 and CD8 T-cells from NOR mice and NOD stocks congenic for NOR-derived Idd resistance loci. Tetramer staining and mimotope stimulation tested the frequency and proliferative capacity of CD4 BDC2.5-like cells. Regulatory T-cells (Tregs) were identified by Foxp3 staining and functionally assessed by in vitro suppression assays.
  
  
  RESULTS
  NOR CD4 T-cells were less diabetogenic than those from NOD mice. The failure of NOR CD4 T-cells to induce type 1 diabetes was not due to decreased proliferative capacity of BDC2.5 clonotypic-like cells. The frequency and function of Tregs in NOD and NOR mice were also equivalent. However, bone marrow chimerism experiments demonstrated that intrinsic factors inhibited the pathogenic activity of NOR CD4 T-cells. The NOR Idd9/11 resistance region on chromosome 4 was found to diminish the diabetogenic activity of CD4 but not CD8 T-cells.
  
  
  CONCLUSIONS
  In conclusion, we demonstrated that a gene(s) within the Idd9/11 region regulates the diabetogenic activity of CD4 T-cells.
authors.affiliation: The Jackson Laboratory, Bar Harbor, ME, USA.
authors.forename: Yi-Guang
authors.initials: YG
authors.lastname: Chen
authors.forename: Felix
authors.initials: F
authors.lastname: Scheuplein
authors.forename: Melissa A
authors.initials: MA
authors.lastname: Osborne
authors.forename: Shirng-Wern
authors.initials: SW
authors.lastname: Tsaih
authors.forename: Harold D
authors.initials: HD
authors.lastname: Chapman
authors.forename: David V
authors.initials: DV
authors.lastname: Serreze
mesh_terms: D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology / Q000473:pathology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology* / Q000473:pathology; D016827:CD8 Antigens / Q000235:genetics / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology / Q000473:pathology; D002874:Chromosome Mapping; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics* / Q000276:immunology* / Q000473:pathology; D020022:Genetic Predisposition to Disease; D008285:Major Histocompatibility Complex; D051379:Mice; D008810:Mice, Inbred C57BL; D016688:Mice, Inbred NOD / Q000235:genetics*; D016513:Mice, SCID; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000235:genetics / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology / Q000473:pathology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology / Q000473:pathology
chemical_list: D016827:CD8 Antigens; D016693:Receptors, Antigen, T-Cell, alpha-beta
references.citation: Immunity. 2000 Jul;13(1):107-15
references.pmid: 10933399
references.citation: J Immunol. 2006 Nov 15;177(10):7033-41
references.pmid: 17082619
references.citation: J Exp Med. 2004 Jun 7;199(11):1467-77
references.pmid: 15184500
references.citation: Am J Hum Genet. 2000 Jul;67(1):67-81
references.pmid: 10848492
references.citation: Immunol Rev. 2005 Apr;204:250-63
references.pmid: 15790363
references.citation: Immunogenetics. 1994;39(4):286-8
references.pmid: 7907077
references.citation: J Immunol. 2001 Oct 15;167(8):4351-7
references.pmid: 11591759
references.citation: J Exp Med. 2004 Jun 7;199(11):1479-89
references.pmid: 15184501
references.citation: J Exp Med. 1994 Oct 1;180(4):1553-8
references.pmid: 7931087
references.citation: J Immunol. 1998 Feb 1;160(3):1472-8
references.pmid: 9570569
references.citation: Diabetes. 1992 Jan;41(1):98-106
references.pmid: 1727742
references.citation: Int Immunol. 2005 Mar;17(3):307-14
references.pmid: 15684037
references.citation: Annu Rev Immunol. 2005;23:447-85
references.pmid: 15771578
references.citation: J Immunol. 1993 Mar 15;150(6):2534-43
references.pmid: 8450229
references.citation: J Immunol. 2005 Sep 1;175(5):3053-9
references.pmid: 16116193
references.citation: Eur J Immunol. 2002 Dec;32(12):3657-66
references.pmid: 12516557
references.citation: Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20878-83
references.pmid: 18093919
references.citation: J Immunol. 2004 Jan 15;172(2):871-9
references.pmid: 14707058
references.citation: Curr Dir Autoimmun. 2001;4:31-67
references.pmid: 11569409
references.citation: Genes Immun. 2005 Sep;6(6):528-38
references.pmid: 16015371
references.citation: J Immunol. 1988 Jun 1;140(11):3801-7
references.pmid: 2897395
references.citation: J Autoimmun. 2005 Aug;25(1):13-20
references.pmid: 15998581
references.citation: J Immunol. 2004 Oct 1;173(7):4407-16
references.pmid: 15383571
references.citation: J Immunol. 2003 Jul 1;171(1):185-95
references.pmid: 12816997
references.citation: Nat Genet. 2007 Mar;39(3):329-37
references.pmid: 17277778
references.citation: Diabetes. 1998 Aug;47(8):1212-8
references.pmid: 9703319
references.citation: J Immunol. 1997 Apr 15;158(8):3978-86
references.pmid: 9103469
references.citation: J Immunol. 1999 Apr 15;162(8):4614-26
references.pmid: 10202001
references.citation: Trends Endocrinol Metab. 2006 May-Jun;17(4):128-35
references.pmid: 16580840
references.citation: Clin Immunol. 2002 Dec;105(3):332-41
references.pmid: 12498815
references.citation: J Clin Invest. 2003 Sep;112(6):902-14
references.pmid: 12975475
references.citation: Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12538-43
references.pmid: 9770521
references.citation: Immunity. 2004 May;20(5):563-75
references.pmid: 15142525
references.citation: J Exp Med. 1997 Oct 6;186(7):1059-75
references.pmid: 9314555
references.citation: Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11533-8
references.pmid: 11572996
references.citation: J Immunol. 1998 Oct 15;161(8):3912-8
references.pmid: 9780157
references.citation: Nat Immunol. 2001 Dec;2(12):1117-25
references.pmid: 11713466
references.citation: Biochim Biophys Acta. 2006 Apr;1762(4):440-6
references.pmid: 16481151
references.citation: J Immunol. 2002 May 15;168(10):5032-41
references.pmid: 11994455
references.citation: Diabetes. 2002 Aug;51(8):2481-8
references.pmid: 12145161
references.citation: J Immunol. 1991 Aug 15;147(4):1222-9
references.pmid: 1869820
references.citation: J Immunol. 2005 Feb 1;174(3):1196-204
references.pmid: 15661873
references.citation: J Immunol. 2000 Apr 1;164(7):3913-8
references.pmid: 10725754
references.citation: Blood. 2006 Jan 15;107(2):594-601
references.pmid: 16195331
references.citation: J Immunol. 2004 Aug 15;173(4):2530-41
references.pmid: 15294969